4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-036513
Director sold 1,666 shares at an average $65.37 ($108,911)
From the SEC's structured data for this filing
Trades in this filing
SATO VICKI L · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-26 | Sale : show line 1 in the form | −894 | $64.90 | $58,022 | 134,861 | D |
| 2021-05-26 | Sale : show line 2 in the form | −732 | $65.88 | $48,221 | 134,129 | D |
| 2021-05-26 | Sale : show line 3 in the form | −40 | $66.72 | $2,669 | 134,089 | D |
| Open-market sales · 1,666 sh · avg $65.37 · $108,911 | ||||||
Loading xslF345X03/doc4.xml…